These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26147133)

  • 1. You Are What You Eat: Metabolites of Gut Microbiota Provide Novel Insights into Diagnosis and Development of Chronic Kidney Disease.
    Quante M
    Transplantation; 2015 Jul; 99(7):1306-7. PubMed ID: 26147133
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease.
    Mafra D; Lobo JC; Barros AF; Koppe L; Vaziri ND; Fouque D
    Future Microbiol; 2014; 9(3):399-410. PubMed ID: 24762311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New aspects on the metabolic role of intestinal microbiota in the development of atherosclerosis.
    Drosos I; Tavridou A; Kolios G
    Metabolism; 2015 Apr; 64(4):476-81. PubMed ID: 25676802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gut microbiome, diet, and links to cardiometabolic and chronic disorders.
    Aron-Wisnewsky J; Clément K
    Nat Rev Nephrol; 2016 Mar; 12(3):169-81. PubMed ID: 26616538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of NMR-based metabolomics to the study of gut microbiota in obesity.
    Calvani R; Brasili E; Praticò G; Sciubba F; Roselli M; Finamore A; Marini F; Marzetti E; Miccheli A
    J Clin Gastroenterol; 2014; 48 Suppl 1():S5-7. PubMed ID: 25291128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease.
    Anders HJ; Andersen K; Stecher B
    Kidney Int; 2013 Jun; 83(6):1010-6. PubMed ID: 23325079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary protein metabolism by gut microbiota and its consequences for chronic kidney disease patients.
    Mafra D; Barros AF; Fouque D
    Future Microbiol; 2013 Oct; 8(10):1317-23. PubMed ID: 24059921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases.
    Brown JM; Hazen SL
    Annu Rev Med; 2015; 66():343-59. PubMed ID: 25587655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabonomic biomarkers for risk factors of chronic kidney disease.
    Ye L; Mao W
    Int Urol Nephrol; 2016 Apr; 48(4):547-52. PubMed ID: 26897037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal microbiota produced trimethylamine-N-oxide can increase the risk of cardiovascular disease.
    Khan MS; Bawany FI; Khan A
    J Pak Med Assoc; 2014 Apr; 64(4):488. PubMed ID: 24864657
    [No Abstract]   [Full Text] [Related]  

  • 11. Gut microbiota metabolism of L-carnitine and cardiovascular risk.
    Ussher JR; Lopaschuk GD; Arduini A
    Atherosclerosis; 2013 Dec; 231(2):456-61. PubMed ID: 24267266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What would you like to eat, Mr CKD Microbiota? A Mediterranean Diet, please!
    Montemurno E; Cosola C; Dalfino G; Daidone G; De Angelis M; Gobbetti M; Gesualdo L
    Kidney Blood Press Res; 2014; 39(2-3):114-23. PubMed ID: 25117687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota, the genome, and diet in atherogenesis.
    Loscalzo J
    N Engl J Med; 2013 Apr; 368(17):1647-9. PubMed ID: 23614591
    [No Abstract]   [Full Text] [Related]  

  • 14. Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease.
    Hung SC; Kuo KL; Wu CC; Tarng DC
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28174171
    [No Abstract]   [Full Text] [Related]  

  • 15. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
    Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
    J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic biomarkers for chronic kidney disease.
    Breit M; Weinberger KM
    Arch Biochem Biophys; 2016 Jan; 589():62-80. PubMed ID: 26235490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diet, microbiota, and colorectal cancer.
    Akin H; Tözün N
    J Clin Gastroenterol; 2014; 48 Suppl 1():S67-9. PubMed ID: 25291132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic kidney disease what is it?].
    Joly D
    Rev Prat; 2012 Jan; 62(1):34-7. PubMed ID: 22335064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial dysfunction and gut microbiota imbalance: An intriguing relationship in chronic kidney disease.
    Mafra D; Borges NA; Lindholm B; Stenvinkel P
    Mitochondrion; 2019 Jul; 47():206-209. PubMed ID: 30408595
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolomics and renal disease.
    Rhee EP
    Curr Opin Nephrol Hypertens; 2015 Jul; 24(4):371-9. PubMed ID: 26050125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.